Training in screening for SARS-CoV-2 mutations in partner laboratories in Togo (BIOLIM) and Benin (LFHV)
Training in screening for SARS-CoV-2 mutations in partner laboratories in Togo (BIOLIM) and Benin (LFHV)
As part of the AFROSCREEN project, trainings are intended to strengthen the capacities of laboratories in partner countries, particularly in the field of screening for SARS-CoV-2 mutations.
Feedback on the two training courses in screening PCR, organized over 2 days each, in March 2022, within the LFHV and BIOLIM laboratories, by the company Innovative Diagnostics, technical partner of the IRD on the screening activities within the framework of the AFROSCREEN project.
Practical application to consolidate the achievements of the training – the BIOLIM team and the two trainers. From left to right: Mr. Amenti, Mrs. Koubevi, Mr. Saulde, Mr. TeguenI, Mrs. Kagnissode, Mrs. Comlan and Mrs. Sigbessia
In March 2022, Benjamin Sauldé and Claudia Koubevi from Innovative Diagnostics trained the personnel of the BIOLIM Laboratory in Togo (16-17/03/2022) and the LFHV in Benin (30-31/03/2022) to screen for SARS-CoV-2 mutations by PCR using the DICOV-MOC/I kit, developed by the company Innovative Diagnostics.
This training, together with the supply of reagents and the loan of a specific thermal cycler by the company to these two laboratories, enables them to search for mutations in the viruses detected in samples collected in Togo and Benin.
As part of the project, the BIOLIM laboratories (Togo), the IRCB and the LFHV (Benin) are in charge of carrying out the sequencing (BIOLIM and IRCB) and the screening of mutations by PCR (BIOLIM and LFHV) of national samples, and to collect and analyze epidemiological data (BIOLIM and IRCB) on the samples that reveal the presence of variants of concern.
The reinforcement by AFROSCREEN of the capacities of these three laboratories consists not only in the training of their staff (training in sequencing, screening PCR, bioinformatics analysis, phylogeny, etc.), but also in the acquisition equipment, reagents and consumables needed to carry out laboratory activities. Thus, during the first half of 2022, BIOLIM and the IRCB will notably be equipped with an NGS (Next Generation Sequencing) sequencer allowing them to start sequencing SARS-CoV-2, and eventually other emerging pathogens.
In addition, through the AFROSCREEN project, the partnership between IRD / UMR TransVIHMI and UMR MERIT and three laboratories is sustainably strengthened.
Practical application to consolidate the achievements of the training – the BIOLIM team and the two trainers. From left to right: Mr. Amenti, Mrs. Koubevi, Mr. Saulde, Mr. TeguenI, Mrs. Kagnissode, Mrs. Comlan and Mrs. Sigbessia
In March 2022, Benjamin Sauldé and Claudia Koubevi from Innovative Diagnostics trained the personnel of the BIOLIM Laboratory in Togo (16-17/03/2022) and the LFHV in Benin (30-31/03/2022) to screen for SARS-CoV-2 mutations by PCR using the DICOV-MOC/I kit, developed by the company Innovative Diagnostics.
This training, together with the supply of reagents and the loan of a specific thermal cycler by the company to these two laboratories, enables them to search for mutations in the viruses detected in samples collected in Togo and Benin.
As part of the project, the BIOLIM laboratories (Togo), the IRCB and the LFHV (Benin) are in charge of carrying out the sequencing (BIOLIM and IRCB) and the screening of mutations by PCR (BIOLIM and LFHV) of national samples, and to collect and analyze epidemiological data (BIOLIM and IRCB) on the samples that reveal the presence of variants of concern.
The reinforcement by AFROSCREEN of the capacities of these three laboratories consists not only in the training of their staff (training in sequencing, screening PCR, bioinformatics analysis, phylogeny, etc.), but also in the acquisition equipment, reagents and consumables needed to carry out laboratory activities. Thus, during the first half of 2022, BIOLIM and the IRCB will notably be equipped with an NGS (Next Generation Sequencing) sequencer allowing them to start sequencing SARS-CoV-2, and eventually other emerging pathogens.
In addition, through the AFROSCREEN project, the partnership between IRD / UMR TransVIHMI and UMR MERIT and three laboratories is sustainably strengthened.